• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

AI Mental Health Chatbot Predicts Disorders with 93% Accuracy

by Syed Hamza Sohail 01/23/2023 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
AI Mental Health Chatbot Diagnoses Disorders with 93% Accuracy

What You Should Know:

– London-headquartered digital health startup, Limbic, has announced that its psychological assessment tool, Limbic Access, has achieved Class IIa UKCA medical device certification – making it the first and only AI mental health chatbot in the world to earn this status for its clinical effectiveness, safety and risk management.

– The certification confirms that its mental health e-triage chatbot, which is able to predict mental health disorders with an accuracy rate of 93%, can be safely incorporated into the psychological therapy pathway to support patient self-referral – driving significant efficiencies to support overstretched clinicians and improving patient outcomes. 

Health tech start-up achieves world-first certification for AI mental health chatbot that diagnoses disorders with 93% accuracy


It comes as NHS Improving Access to Psychological Therapies (IAPT) services are experiencing significant capacity challenges in the face of record demand – with latest data showing a 21.5% increase in people accessing NHS talking therapies services over the last year.

130,000 NHS patients have so far accessed psychological therapy using Limbic’s AI mental health chatbot, making it the most widely used solution of its kind in the NHS. UKCA auditors, SGS, reviewed clinical evidence generated from more than 60,000 referrals and found that, when compared with standard referral methods such as telephone calls and online forms,

Limbic Access delivered:

1. 53% improvement in recovery rates 

2. 45% fewer changes in treatment, due to increased triage accuracy

3. 23.5% reduction in assessment time – a saving of 12.7 minutes per referral 

4. 18% reduction in treatment dropouts

5. 13% reduction in wait time for assessment 

6. 5% shorter wait time for treatment 

Limbic Access is already working with 25% of NHS IAPTs to augment their therapy process and, to date, it is estimated to have saved IAPT services in England more than 30,000 clinical hours. At a time when the NHS is massively overburdened – latest data shows a 16.2% increase in the number of people in contact with NHS mental health services over the last 12 months – this is critical time released for staff. 

Through Limbic Access and its sister product, Limbic Care – designed to provide personalised support and remote monitoring for patients in treatment – the rapidly growing tech company has created an end-to-end solution for talk therapy that’s designed to augment psychological therapy from start to finish.

As well as being the only Class IIa UKCA marked psychological assessment tool, Limbic Access was awarded the highest score of any level 4 mental health app by ORCHA, the UK’s leading healthcare app evaluation organisation. It is currently the only mental health e-triage chatbot to have been through ORCHA’s rigorous review process.

“This is a landmark moment for mental healthcare, as it provides strong evidence that our psychological assessment software – the first in the world to gain this level of certification – is a safe and clinically effective way to augment the therapy process within mental health services at a time when such support has never been more needed,” said Dr Ross Harper, co-founder and CEO of Limbic. 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: AI, Artificial Intelligence, digital health, Medical Device, Mental Health, Mental Healthcare, NHS, risk, safety and risk management

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Knowledge Hub

 How Top Health Plans Use AI to Save Money and Work Smarter How Top Health Plans Use AI to Save Money and Work Smarter

 How to Build Hybrid Care Models Around Remote Patient Monitoring How to Build Hybrid Care Models Around Remote Patient Monitoring

Trending

Olive Secures $400M At A $4B Valuation to Support New Instant Claim Payment Solution

Olive Shutters Business After Sale to Waystar and Humata Health

Clinician Shortage Worsens Primary Care Crisis, Experts Reveal

Clinician Shortage Worsens Primary Care Crisis, Experts Reveal

FDA Grants Clearance for UltraSight's AI Cardiac Ultrasound

Israel Defense Forces to Utilize UltraSight’s PoCUS Devices in Combat

The Future of Biomarker-Based Therapy for Mental Disorder Care

The Future of Biomarker-Based Therapy for Mental Disorder Care

HLTH23: 6 Digital Health Executives Share Key Takeaways

6 Digital Health Executives Share Key Takeaways from HLTH23

HIMSS Appoints New Chief Financial Officer & General Counsel

HIMSS Appoints New Chief Financial Officer & General Counsel

GoodRx Now Offers Access to $35 Insulin to All Americans

GoodRx Now Offers Access to $35 Insulin to All Americans

Ozempic: From Diabetes Management to Potential Weight Loss Miracle

Ozempic: From Diabetes Management to Potential Weight Loss Miracle

Health M&A: Financial Distress Driving Q3 Healthcare Deals

Health M&A: Financial Distress Driving Q3 Healthcare Deals

GE HealthCare Inks $44M Contract with BARDA to Develop AI-Driven Ultrasound Tech

GE HealthCare Inks $44M Contract with BARDA to Develop AI-Driven Ultrasound Tech

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |